The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD

The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.